Shareholding disclosure

Cosmo Pharmaceuticals NV

Declared position

9.5%

Threshold

Crossed downwards

Timeline

Published

12.12.2018

Transaction

29.11.2018

Voting rights breakdown

Voting rights acquired0%

Voting rights sold9.5%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAICA000H3

Beneficial owner

Cosmo Pharmaceuticals NV

Declared address

Cosmo Pharmaceuticals NV, Dublin 2

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Cosmo Pharmaceuticals NV

Cosmo N.V.12.12.2018TAICA000H3

Disclosure summary

Cosmo Pharmaceuticals NV disclosed a holding in Cosmo N.V. on the disposal side, published by SIX Exchange Regulation on 12.12.2018, at 9.5% of voting rights. Notice category: Single shareholder.

Disclosed position

9.5%

Voting rights sold

Voting rights acquired0%

Voting rights sold9.5%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Cosmo Pharmaceuticals NV disclosed a holding in Cosmo N.V., published on 12.12.2018.

Publication date12.12.2018

Transaction date29.11.2018

Issuing companyCosmo N.V.

Beneficial ownerCosmo Pharmaceuticals NV

Declared addressCosmo Pharmaceuticals NV, Dublin 2

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold9.5%

Below threshold0%

ExchangeXSWX

Notification IDTAICA000H3

Source: SIX Exchange Regulation · Publication date: 12.12.2018

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open